These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18192823)

  • 21. Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006.
    Escaned J; Rydén L; Zamorano JL; Poole-Wilson P; Fuster V; Gitt A; Fernández-Avilés F; Scholte Op Reimer W; de Teresa E; Alonso-Pulpón L; Tendera M;
    Eur Heart J; 2007 Mar; 28(5):634-7. PubMed ID: 17283000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, atherosclerosis and predicting cardiovascular risk.
    Williams M; Stewart R
    N Z Med J; 2002 Oct; 115(1163):U196. PubMed ID: 12552302
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recommendations for the prevention of cardiovascular diseases in clinical practice].
    De Backer G; De Bacquer D; Brohet C; De Ceukelier S; Franck A; Krzentowsky G; Legat P; Pochet JM; Scheen A;
    J Pharm Belg; 2005; 60(2):41-50. PubMed ID: 16035368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stair use for cardiovascular disease prevention.
    Meyer P; Kayser B; Mach F
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S17-8. PubMed ID: 19675430
    [No Abstract]   [Full Text] [Related]  

  • 25. Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
    Undas A; Podolec P; Kopeć G; Pajak A; Gasior Z; Małecki M; Pasowicz M; Rynkiewicz A; Torbicki A; Zdrojeski T; Czarnecka D; Drygas W; Godycki-Cwirko M; Kozek E; Naruszewicz M; Opala G; Stańczyk J; Sieradzki J
    Kardiol Pol; 2007 Nov; 65(11):1396-8. PubMed ID: 18303602
    [No Abstract]   [Full Text] [Related]  

  • 26. Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.
    Masi S; Charakida M; Wang G; O'Neill F; Taddei S; Deanfield J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S61-4. PubMed ID: 19675441
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new European concept for prevention of cardiovascular diseases].
    Orth-Gomér K
    Lakartidningen; 2004 May; 101(20):1774-5. PubMed ID: 15190765
    [No Abstract]   [Full Text] [Related]  

  • 28. AHA examines cardiovascular problems in diabetes. American Heart Association.
    Morey SS
    Am Fam Physician; 2000 Jan; 61(2):561, 563-4, 567. PubMed ID: 10670513
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyslipidaemia and vascular risk. A new evidence based review].
    Pallarés-Carratalá V; Pascual-Fuster V; Godoy-Rocatí D
    Semergen; 2015; 41(8):435-45. PubMed ID: 25559484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New European guidelines on cardiovascular disease prevention].
    Perk J
    Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1463. PubMed ID: 22993894
    [No Abstract]   [Full Text] [Related]  

  • 33. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries.
    Campbell SM; Ludt S; Van Lieshout J; Boffin N; Wensing M; Petek D; Grol R; Roland MO
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):509-15. PubMed ID: 18695594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.
    Wajed J; Ahmad Y; Durrington PN; Bruce IN
    Rheumatology (Oxford); 2004 Jan; 43(1):7-12. PubMed ID: 12867578
    [No Abstract]   [Full Text] [Related]  

  • 37. The cardiovascular prevention and lifestyle quiz for cardiologists.
    De Sutter J; Conraads VM
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
    [No Abstract]   [Full Text] [Related]  

  • 38. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular risk in inflammatory systemic disease should be assessed regularly. The Swedish Society of Rheumatology has formulated guidelines for primary prevention].
    Jonsson SW; Ljung L; D'Elia HF; Henrohn D; Turesson C; Svenungsson E
    Lakartidningen; 2012 Jan 11-17; 109(1-2):27-9. PubMed ID: 22468407
    [No Abstract]   [Full Text] [Related]  

  • 40. [Misunderstandings without limits].
    Jervell J
    Tidsskr Nor Laegeforen; 2005 Feb; 125(4):463. PubMed ID: 15742025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.